Lazard Asset Management
SGMO

Lazard Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Lazard Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,668
Closed -$1K – 2511
2025
Q1 		$1K Sell
2,668
-43,795
-94% -$46.4K ﹤0.01% 2265
2024
Q4 		$47K Buy
+46,463
New +$84.9K ﹤0.01% 1982
2024
Q3 		– Sell
-865
Closed – – 2437
2024
Q2 		$0 Sell
865
-22,572
-96% -$12.2K ﹤0.01% 2407
2024
Q1 		$15K Sell
23,437
-13,653
-37% -$9.9K ﹤0.01% 1859
2023
Q4 		$19K Buy
37,090
+2,039
+6% +$940 ﹤0.01% 2060
2023
Q3 		$20K Sell
35,051
-45,027
-56% -$48.2K ﹤0.01% 2098
2023
Q2 		$104K Buy
80,078
+67,489
+536% +$92.2K ﹤0.01% 1564
2023
Q1 		$21K Sell
12,589
-11,621
-48% -$33.2K ﹤0.01% 2049
2022
Q4 		$75K Sell
24,210
-2,754
-10% -$10.7K ﹤0.01% 1638
2022
Q3 		$131K Buy
26,964
+45
+0.2% +$231 ﹤0.01% 1369
2022
Q2 		$111K Buy
26,919
+14,751
+121% +$63.8K ﹤0.01% 1472
2022
Q1 		$70K Buy
12,168
+3,342
+38% +$19.9K ﹤0.01% 1565
2021
Q4 		$65K Buy
8,826
+1,560
+21% +$13.6K ﹤0.01% 1629
2021
Q3 		$65K Sell
7,266
-8,990
-55% -$88.9K ﹤0.01% 1568
2021
Q2 		$193K Buy
16,256
+16,030
+7,093% +$181K ﹤0.01% 1220
2021
Q1 		$2K Sell
226
-5,121
-96% -$69K ﹤0.01% 1813
2020
Q4 		$83K Buy
+5,347
New +$62.6K ﹤0.01% 1229

Other funds holding SGMO

YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Lazard Asset Management's SGMO Position: Q2 2025 in Review

Lazard Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2025, closing a stake of 2,668 shares — an estimated $1K sold.

Lazard Asset Management first reported a position in SGMO in Q4 2020 and held it in 17 quarters. The position peaked at $193K in Q2 2021. 114 funds tracked by Wall St. Rank hold SGMO as of Q2 2025.

  • Lazard Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 2,668 SANGAMO THERAPEUTICS INC shares in Q2 2025, an estimated $1K.
  • Lazard Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 17 quarters.
  • Lazard Asset Management's SANGAMO THERAPEUTICS INC position peaked at $193K in Q2 2021.
  • 114 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.